The ASPC Congress on CVD Prevention is taking place in Arlington, Texas, July 21-23. Here, G.B. John Mancini, MD, University of British Columbia, emphasizes the importance of having an international perspective on preventive cardiology.
Cardiovascular disease is one of the most common and costly health care problems worldwide, and preventive cardiology can be discussed as secondary, primary, or primordial. There is tremendous opportunity to work multilaterally, emphasized G.B. John Mancini, MD, professor of medicine; scientific director, Cardio Risk Clinic; and director of the Cardiovascular Imaging Research Core Laboratory, University of British Columbia.
On Day 1 of the American Society for Preventive Cardiology’s Congress on CVD Prevention, in the session, “What Is Preventive Cardiology,” Mancini presented, “The Canadian Perspective.”
Transcript
What is preventive cardiology, and why it is important to have an international perspective on this disease?
Cardiovascular disease is one of the most common and costly health care problems worldwide, and so preventive cardiology is generally discussed as secondary or primary or primordial. For example, secondary prevention would be, if someone has had a heart attack, you never want them to have another one—so you would treat accordingly all the risk factors. Primary prevention is someone who you don't want to have a heart attack, but you know they have risk factors—they may have high blood pressure or they smoke—and so you want to deal with those things. Primordial prevention is avoiding the risk factors altogether—we don't want our kids to become obese or to develop diabetes or to start smoking, etc.
So this conference, one of the themes is what is exactly preventive cardiology and who should be doing it. I think that there's tremendous opportunity to work multilaterally. We have representation here from Europe; from Canada, through myself; and the US, talking about the training challenges, the clinical challenges of what is currently a multidisciplinary system, but which of course requires core competencies—whether this person is a cardiologist or an endocrinologist or what have you—and what those core competencies should be and how they should be delivered. Training programs is an area that I think is fruitful to pursue as a result of this conference.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More